{"id":1316,"date":"2020-08-26T09:33:42","date_gmt":"2020-08-26T09:33:42","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/sexual-transmission-of-ebola-virus-in-liberia-confirmed\/"},"modified":"2021-01-08T11:10:30","modified_gmt":"2021-01-08T11:10:30","slug":"sexual-transmission-of-ebola-virus-in-liberia-confirmed","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/sexual-transmission-of-ebola-virus-in-liberia-confirmed\/","title":{"rendered":"Sexual transmission of Ebola Virus in Liberia confirmed"},"content":{"rendered":"

A suspected case of sexual transmission of Ebola virus disease (EVD) in Liberia was confirmed using genomic analysis, thanks to in-country laboratory capabilities established by U.S. Army scientists in collaboration with the Liberian Institute for Biomedical Research (LIBR).
\nThe work provides molecular evidence of Ebola virus (EBOV) transmission between an EVD survivor and his female partner. It also demonstrates the value of real-time genomic surveillance during an outbreak, according to senior author Gustavo Palacios, Ph.D., of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).<\/p>\n

CPT Suzanne Mate, Ph.D., of USAMRIID, said scientists working at the LIBR earlier this year analysed blood samples from a female patient who tested positive for EBOV in March 2015 when there had been no new documented cases for 30 days. The patient was reported have had recent sexual intercourse with a male partner who had survived EVD and had been declared EBOV negative in early October 2014.<\/p>\n

Following the patient\u2019s death on March 27, Mate said, public health officials were able to secure the consent of the male survivor to obtain and test a semen sample from him. The semen sample tested EBOV positive by quantitative RT-PCR, but the assay indicated that the level of viral RNA was low and required a different sample preparation method than the one originally deployed to sequence EBOV RNA from acute samples.<\/p>\n

\u201cWe implemented a new enrichment strategy in collaboration with scientists from Illumina, Inc. that was pivotal in obtaining the required coverage to complete downstream genomic analysis,\u201d said Michael Wiley, Ph.D, of USAMRIID. Next-generation sequencing of the enriched EBOV RNA extracted from the male survivor\u2019s semen was used to compare the genome for similarity to the virus RNA extracted from the female patient\u2019s blood sample.<\/p>\n

\u201cEbola virus genomes assembled from the patient\u2019s blood and the survivor\u2019s semen were consistent with direct transmission,\u201d commented Jason Ladner, Ph.D., of USAMRIID. \u201cThe samples shared three genetic substitutions that have not been found in any other Ebola virus sequences in Western Africa.\u201d<\/p>\n

In addition, said Ladner, these three genetic changes were distinct from the last
\ndocumented transmission chain in Liberia prior to this case. Combined with epidemiologic data, the genomic analysis provides support for sexual transmission of Ebola virus and for the persistence of infective EBOV in semen for more than 179 days after disease onset. This caused both the Centers for Disease Control and Prevention and the World Health Organization to change their recommendations for convalescent patients regarding sexual contact until more definitive information is obtained about how long Ebola virus can persist in semen.\nResearch Institute of Infectious Diseases<\/link>\n","protected":false},"excerpt":{"rendered":"

A suspected case of sexual transmission of Ebola virus disease (EVD) in Liberia was confirmed using genomic analysis, thanks to in-country laboratory capabilities established by U.S. Army scientists in collaboration with the Liberian Institute for Biomedical Research (LIBR). The work provides molecular evidence of Ebola virus (EBOV) transmission between an EVD survivor and his female […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1316"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=1316"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1316\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=1316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=1316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=1316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}